This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities.
The financial opportunity within the biologics fill finish services market has been analysed across the following segments:
§ Type of Packaging Container
§ Ampoules
§ Cartridges
§ Syringes
§ Vials
§ Type of Biologic
§ Antibodies
§ Cell Therapies
§ Gene Therapies
§ Oligonucleotides
§ Proteins / Peptides
§ Vaccines
§ Others
§ Therapeutic Area
§ Oncological Disorders
§ Autoimmune Disorders
§ Infectious Diseases
§ Cardiovascular Disorders
§ Other Disorders
§ Scale of Operation
§ Preclinical / Clinical
§ Commercial
§ Company Size
§ Large
§ Mid-sized
§ Small
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Middle East and North Africa
- Latin America
The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:
§ AbbVie Contract Manufacturing
§ Asymchem
§ BioReliance
§ Boehringer Ingelheim BioXcellence
§ Catalent Biologics
§ Charles River Laboratories
§ Fareva
§ Fresenius Kabi
§ Glaxo SmithKline
§ Hetero Drugs
§ Intas Pharmaceuticals
§ Lonza
§ Patheon
§ Pierre Fabre
§ Recipharm
§ Samsun Biologics
§ Syngene
§ Takara Bio
§ Wacker Biotech
§ WuXi AppTec
§ WuXi Biologics
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Biologics Fill / Finish Service Providers: Market Landscape
5. Company Competitiveness Analysis
6. Biologics Fill / Finish Service Providers in North America
7. Biologics Fill / Finish Service Providers in Europe
8. Biologics Fill / Finish Service Providers in Asia-Pacific
9. Recent Partnerships
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish
14. Regional Capability Assessment
15. Biologics Fill Finish Market Sizing and Opportu
